Clinical Trial

Faecal Incontinence in Prostate Cancer Survivors Treated Whith Radiotherapy

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The objective of the study is to determine the incidence of faecal incontinence in prostate cancer survivors treated with moderately hypofractionated radiation therapy and correlate the dose received by the anal sphincter with the degree of faecal incontinence.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2020-02-07; most recent amendment 2026-03-18.
Status change: Recruiting → Active, Not Recruiting 2024-02-06
Status change: Not Yet Recruiting → Recruiting 2021-07-30
Trial Details
NCT Number NCT04262609
Lead Sponsor Consorci Sanitari de Terrassa
Conditions Faecal Incontinence, Prostate Cancer
Enrollment 200 participants
Start Date 2019-07-01
Primary Completion 2026-02-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-19